Mutation Profiling of Uterine Lavage Fluid: Detection of Early Stage Endometrial Cancers

16 January 2017

This presentation, given at AMP 2016 by John Martignetti, MD, PhD, from the Laboratory of Translational Research, The Mount Sinai Hospital, discusses the development of a tool for the early detection of endometrial cancers. John Martignetti describes his research into developing the established Molecular Signature Method (MSM) into a diagnostic tool. The presentation covers the theory behind the method, results from a prospective study and the future directions of the research.